Ads
related to: fda approved tongue strengthening device
Search results
Results from the WOW.Com Content Network
The device, called Portable Neuromodulation Stimulator (PoNS), is a neuromuscular tongue stimulator that consists of a non-implantable apparatus to generate electrical pulses for stimulation of the trigeminal and facial nerves via the tongue to provide treatment of motor deficits. [125]
BrainPort is a technology whereby sensory information can be sent to one's brain through an electrode array which sits atop the tongue. [1] It was initially developed by Paul Bach-y-Rita as an aid to people's sense of balance, particularly of stroke victims. Bach-y-Rita founded Wicab in 1998. [2] [3] [4]
A tongue depressor or spatula is a tool used in medical practice to depress the tongue to allow for examination of the mouth and throat. Hobbyists , artists, teachers and confectionery makers use tongue depressors, which may also be referred to as craft sticks or popsicle sticks .
Shares of the medical device maker more than doubled to $9.12 in premarket trading. The clearance is the first ever for an oral appliance, along with a mode of respiratory ventilation or exercise ...
The AIO Breathe Device is a “new mandibular repositioning device” that was designed by local sleep physician Dr. Raghavendra V. Ghuge, MD, MBA, DABSM, […] FDA clears Tyler company’s device ...
[74] [75] In January 2018, the FDA cleared a new use of that device, for the treatment of migraine pain in adults under a 510(k) based on the de novo clearance. [ 76 ] [ 77 ] In 2020, electroCore's non-invasive VNS was granted an Emergency Use Authorization for treating COVID-19 patients, given Research has shown this pulse train causes airways ...
For use with laptop, tablets, or smartphones, this Bluetooth- and motion-enabled product is first custom-fitted to the wearer with dental-grade materials, and once wirelessly paired, enables hands ...
In combination with pemetrexed and platinum-based chemotherapy for the first-line treatment of adults with locally advanced or metastatic non- small cell lung cancer whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test [2] Osimertinib
Ads
related to: fda approved tongue strengthening device